Quantcast
Last updated on April 20, 2014 at 14:04 EDT

Latest Proton pump inhibitors Stories

2013-07-15 12:25:24

NEXIUM YouTube Channel Provides Information on Acid Reflux Disease, Symptom Relief and Savings WILMINGTON, Del., July 15, 2013 /PRNewswire/ -- Acid reflux disease, also known as gastroesophageal reflux disease (GERD), is one of the most common chronic illnesses in the US today, affecting more than 60 million Americans each month.(1 )To help educate consumers about NEXIUM, a prescription treatment option for those diagnosed with GERD, as well as support and empower those living with...

2013-07-10 16:26:00

HOUSTON, July 10, 2013 /PRNewswire-USNewswire/ -- Drugs that help millions of people cope with acid reflux may also cause cardiovascular disease, report scientists from Houston Methodist Hospital and two other institutions in an upcoming issue of Circulation (now online). It is the first time researchers have shown how proton pump inhibitors, or PPIs, might cause cardiovascular problems. In human tissue and mouse models, the researchers found PPIs caused the constriction of blood...

2013-05-21 08:28:59

ORLANDO, Fla., May 21, 2013 /PRNewswire-USNewswire/ -- A study presented at Digestive Disease Week® (DDW) suggests that more objective testing may substantially reduce the cost and risk of managing gastroesophageal reflux disease (GERD). GERD is believed to affect nearly 25 percent of adults. Researchers at New York Presbyterian Hospital and Weill-Cornell Medical College found that almost a third of patients undergoing treatment have no measurable signs of the chronic...

2013-05-20 11:15:26

Studies presented at DDW® 2013 also highlight patient risks There are significant cost and risk factors associated with two procedures commonly used to diagnose or treat gastrointestinal problems, according to research presented at Digestive Disease Week® (DDW). A study by New York Presbyterian Hospital and Weill-Cornell Medical College suggests that more objective testing may substantially reduce the cost and risk of managing gastroesophageal reflux disease (GERD). Although...

2013-04-14 23:02:02

Bel Marra Health, who offers high-quality, specially formulated vitamins and nutritional supplements, is reporting on new research that shows how female patients are up to 50% more likely to suffer from hip fractures if they take heartburn medication. Toronto, ON (PRWEB) April 14, 2013 Bel Marra Health, who offers high-quality, specially formulated vitamins and nutritional supplements, is reporting on new research that shows how female patients are up to 50% more likely to suffer from hip...

2013-03-26 20:22:33

WOODCLIFF LAKE, N.J., March 26, 2013 /PRNewswire/ -- Eisai Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved ACIPHEX(®) Sprinkle(TM) Delayed-Release Capsules 5mg and 10mg for the treatment of Gastroesophageal Reflux Disease (GERD) in children 1 to 11 years of age for up to 12 weeks. "We are proud to offer a new treatment option for young children who suffer from GERD," said Lonnel Coats, president and CEO of Eisai Inc. "Eisai is committed to keeping the...

2013-03-22 23:03:16

Court data updated on March 5th, 2013, by the US Judicial Panel on Multi-District Litigation (MDL), indicate that there are 42 actions currently pending in the Nexium MDL. In light of these news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Nexium side effects. San Diego, CA (PRWEB) March 22, 2013 AttorneyOne.com, a recognized authority on law, updated the website...

2013-03-18 23:02:23

The law firm of d´Oliveira & Associates, has announced a “No Win — No Fee Promise” to any clients that have suffered any of the side effects of Prilosec and may be entitled to compensation. (PRWEB) March 18, 2013 Originally put on the market in 1989 by AstraZeneca, Prilosec is a member of a class of drugs called Proton Pump Inhibitors (PPIs). These drugs (including popular drugs Prilosec and Nexium) have been linked to loss of bone density in patients similar to...

2013-03-05 16:24:32

BETHESDA, Md., March 5, 2013 /PRNewswire-USNewswire/ -- New treatment guidelines on the diagnosis and management of gastroesophageal reflux disease (GERD), one of the most prevalent digestive disorders, appear in the March issue of The American Journal of Gastroenterology. The new guidelines from the American College of Gastroenterology provide an overview of GERD and its presentation and offer clinical recommendations for the approach to diagnosis and management of this common condition,...

2013-02-11 12:23:05

BERKELEY HEIGHTS, N.J., Feb. 11, 2013 /PRNewswire/ -- MedAccess, an Access Group Company, graced the cover of the January issue of PM360 as the overall "grand tier" winner of the Pharma Choice Awards, netting a gold in the coveted branded print ad category. The Access Group was also awarded an additional gold and a silver. PM360, a leading health-marketing industry trade magazine, recognizes the best print and digital campaigns in the industry. All submissions are placed online, where...